Beranda › Penyakit Kardiovaskular › North Carolina › Durham
Uji klinis Penyakit Kardiovaskular di Durham, NC
17 studi untuk Penyakit Kardiovaskular mencari peserta di lokasi sekitar Durham (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
ELEVATE-HFpEF Clinical Study
Menerima peserta
- Duke University Medical Center, Durham
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Menerima pesertaFase 3
- The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi jauhnya
Product Surveillance Registry
Menerima pesertaStudi observasional
- Durham, Durham
- Chapel Hill, Chapel Hill · 10 mi jauhnya
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Menerima pesertaFase 3
- Clinical Trial Site, Durham
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
Menerima pesertaFase 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 mi jauhnya
Zenith® Fenestrated+ Clinical Study
Menerima peserta
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi jauhnya
Observational Pharmaco-Epidemiology Research & Analysis
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Epividian, Durham
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Menerima peserta
- Duke University, Durham
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Menerima pesertaFase 4Sukarelawan sehat diterima
- PREVENTABLE Tele-Site, Durham
- Duke University, Durham
- University of North Carolina, Chapel Hill · 10 mi jauhnya
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Menerima pesertaFase 3
- Research Site, Durham
- Research Site, Durham
- Research Site, Chapel Hill · 10 mi jauhnya
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Menerima pesertaFase 3
- Duke University Health System, Durham
Global Paradise System US Post Approval Study
Menerima pesertaStudi observasional
- Durham VA Health System, Durham
- University of North Carolina at Chapel Hill School of Medicine, Chapel Hill · 10 mi jauhnya
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Menerima peserta
- UNC Medical Center, Durham
- Duke University, Durham
SPYRAL GEMINI Pilot Study
Menerima peserta
- University of North Carolina (UNC) Memorial Hospital, Chapel Hill · 10 mi jauhnya
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Menerima peserta
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi jauhnya
PKP2-ACM Natural History Study
Menerima pesertaStudi observasional
- Duke University, Durham
Beta-Blocker Influences on Inflammatory and Neural Responses to Stress
Menerima pesertaFase 4Sukarelawan sehat diterima
- Social Neuroscience and Health Laboratory, Chapel Hill · 10 mi jauhnya
Uji klinis Penyakit Kardiovaskular di kota lain
- Boston, MA37 studi
- New York City, NY33 studi
- Washington, DC28 studi
- Houston, TX24 studi
- Dallas, TX23 studi
- Atlanta, GA22 studi
- Cleveland, OH22 studi
- Chicago, IL21 studi
- Philadelphia, PA21 studi
- Pittsburgh, PA20 studi
- St. Louis, MO20 studi
- Nashville, TN18 studi
Studi lain di Durham
- Kanker Payudara64 studi
- Kanker (semua jenis)58 studi
- Kanker Paru Non-Sel Kecil39 studi
- Mieloma Multipel37 studi
- Leukemia Mieloid Akut33 studi
- Kanker Metastatik33 studi
- Kanker Prostat32 studi
- Kanker Paru32 studi
- Kanker Kolorektal28 studi
- Kanker Ovarium27 studi
- Leukemia Limfositik Kronis27 studi
- Gagal Jantung26 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.